Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A Prospective Phase 3 Study of Patients With Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma
Protocol ID
ARST2032
Disease (Sub Disease)
Rhabdomyosarcoma
Diagnosis Stage
Newly diagnosed
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
External Registry ≫
Trial Status
Preparing to Open
Study Type
Treatment
Phase
Phase 3
Age Eligibility
up to 21 years
International registry ID's
NCT05304585
Back to Registry
Study Title A Prospective Phase 3 Study of Patients With Newly Diagnosed Very Low-Risk and Low-Risk Fusion Negative Rhabdomyosarcoma
Protocol ID ARST2032
Disease (Sub Disease) Rhabdomyosarcoma
Diagnosis Stage Newly diagnosed
Sponsor Children's Oncology Group
Collaborators National Cancer Institute (NCI)
Links https://clinicaltrials.gov/ct2/show/NCT05304585
Trial Status Preparing to Open
Study Type Treatment
Phase Phase 3
Age Eligibility up to 21 years
International registry ID's NCT05304585